Last reviewed · How we verify

NCT06235320: PIS-PaB

Paracetamol Effect on Prostaglandins and Blood Pressure

Not yet recruiting Last updated 26 February 2025
What this trial tests

trial testing routine clinical treatment of pain with paracetamol or ibuprofen in Pain in 72 participants. Not yet recruiting.

Timeline
1 March 2025
Primary endpoint
1 March 2026
1 September 2026

Quick facts

Lead sponsorCharite University, Berlin, Germany
StatusNot yet recruiting
Study typeOBSERVATIONAL
Enrollment72
Start date1 March 2025
Primary completion1 March 2026
Estimated completion1 September 2026

Drugs / interventions tested

Conditions studied

Sponsor

Charite University, Berlin, Germany

Who can join

18 and older, any sex, with Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This research program aims to investigate the influence of paracetamol on blood pressure and the cyclooxygenase (COX) - prostaglandine (PG) pathway in patients with pain. Through an observational pilot study, we will use advanced LC/ESI-MS/MS methodology to analyze the COX-OG pathway in plasma and urine. The study will assess the effects of paracetamol compared to ibuprofen, considering different types of pain. The primary focus is to understand the changes in blood pressure and the COX-PG pathway upon initiation or discontinuation of paracetamol, with safety analysis as a secondary consideration.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Pain

Currently open trials in the same condition.

Other Charite University, Berlin, Germany trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06235320.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing